{"id": "patient_01_q0", "query": "Which of the following is NOT part of the current treatment regimen for Mrs. Sample's DLBCL?", "options_scores": {"A": 0.002265950432047248, "B": 0.00017211079830303788, "C": 0.003658032277598977, "D": 0.7443602085113525, "E": 0.0002022170228883624}, "ranked_options": [{"letter": "B", "text": "Rituximab", "avg_nll": 0.00017211079830303788}, {"letter": "E", "text": "Doxorubicin", "avg_nll": 0.0002022170228883624}, {"letter": "A", "text": "Polatuzumab vedotin", "avg_nll": 0.002265950432047248}, {"letter": "C", "text": "Cyclophosphamide", "avg_nll": 0.003658032277598977}, {"letter": "D", "text": "Vincristine", "avg_nll": 0.7443602085113525}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q1", "query": "In the context of Mrs. Sample's other diagnoses, which of the following is NOT accurate based on the provided information?", "options_scores": {"A": 2.473419427871704, "B": 0.6704744100570679, "C": 0.9792401194572449, "D": 1.2584739923477173, "E": 2.595912218093872}, "ranked_options": [{"letter": "B", "text": "She was diagnosed with primary progressive type of multiple sclerosis.", "avg_nll": 0.6704744100570679}, {"letter": "C", "text": "She has a mood disorder.", "avg_nll": 0.9792401194572449}, {"letter": "D", "text": "She has 3-vessel CHD.", "avg_nll": 1.2584739923477173}, {"letter": "A", "text": "She has 2-vessel disease", "avg_nll": 2.473419427871704}, {"letter": "E", "text": "She has pre-existing ALS.", "avg_nll": 2.595912218093872}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q2", "query": "Which chronic, neuroinflammatory disease does Mrs. Sample suffer from? ", "options_scores": {"A": 8.625187873840332, "B": 2.5519654750823975, "C": Infinity, "D": 4.008028030395508, "E": 0.23489578068256378}, "ranked_options": [{"letter": "E", "text": "Autoimmune encephalitis", "avg_nll": 0.23489578068256378}, {"letter": "B", "text": "Dementia", "avg_nll": 2.5519654750823975}, {"letter": "D", "text": "Brain abscess", "avg_nll": 4.008028030395508}, {"letter": "A", "text": "Multiple sclerosis", "avg_nll": 8.625187873840332}, {"letter": "C", "text": "Parkinson", "avg_nll": null}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q3", "query": "Mrs. Sample takes Fingolimod. What is the dosis and when does the patient take it?", "options_scores": {"A": 2.0709455013275146, "B": 1.4952465295791626, "C": 2.247828960418701, "D": 2.9672088623046875, "E": 2.9128658771514893}, "ranked_options": [{"letter": "B", "text": "0.5 mg, 1 capsule at bedtime", "avg_nll": 1.4952465295791626}, {"letter": "A", "text": "0.5 mg, 1 capsule in the morning", "avg_nll": 2.0709455013275146}, {"letter": "C", "text": "50 mg, 1 capsule in the morning", "avg_nll": 2.247828960418701}, {"letter": "E", "text": "70 mg, 1 capsule in the morning", "avg_nll": 2.9128658771514893}, {"letter": "D", "text": "35 mg, 1 capsule at bedtime", "avg_nll": 2.9672088623046875}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q4", "query": "Which therapy regime does the oncology board recommend for Mrs. Sample?", "options_scores": {"A": 5.406481742858887, "B": 5.547727108001709, "C": 4.739563941955566, "D": 1.0997511148452759, "E": 5.241296768188477}, "ranked_options": [{"letter": "D", "text": "6 cycles of R-Pola-CHP", "avg_nll": 1.0997511148452759}, {"letter": "C", "text": "6 cycles of L-Pola-CRP", "avg_nll": 4.739563941955566}, {"letter": "E", "text": "8 cycles of M-Pola-CHZ", "avg_nll": 5.241296768188477}, {"letter": "A", "text": "5 cycles of T-Pola-RHP", "avg_nll": 5.406481742858887}, {"letter": "B", "text": "7 cycles of R-Luna-CHT", "avg_nll": 5.547727108001709}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q5", "query": "Mrs. Sample has bone metastasis, of which one was surgically addressed. Where was this metastasis located? ", "options_scores": {"A": 3.1166231632232666, "B": 3.016623020172119, "C": 0.79045170545578, "D": 1.8946183919906616, "E": 2.6862850189208984}, "ranked_options": [{"letter": "C", "text": "Thoracic vertebra 10", "avg_nll": 0.79045170545578}, {"letter": "D", "text": "Thoracic vertebra 11", "avg_nll": 1.8946183919906616}, {"letter": "E", "text": "Thoracic vertebra 12", "avg_nll": 2.6862850189208984}, {"letter": "B", "text": "Thoracic vertebra 9", "avg_nll": 3.016623020172119}, {"letter": "A", "text": "Thoracic vertebra 8", "avg_nll": 3.1166231632232666}], "correct_answer_letter": "C", "error": null, "method": "local"}
{"id": "patient_01_q6", "query": "On 01/09/2017, Mrs. Sample received a CT scan of her whole body. What kind of contrast agent was used?", "options_scores": {"A": 1.6449264287948608, "B": 3.2374284267425537, "C": 2.684401273727417, "D": 6.899996280670166, "E": 1.013327956199646}, "ranked_options": [{"letter": "E", "text": "Xenetix 350", "avg_nll": 1.013327956199646}, {"letter": "A", "text": "Omnipaque 320", "avg_nll": 1.6449264287948608}, {"letter": "C", "text": "Optiray 320", "avg_nll": 2.684401273727417}, {"letter": "B", "text": "Imeron 400", "avg_nll": 3.2374284267425537}, {"letter": "D", "text": "Gadovist", "avg_nll": 6.899996280670166}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q7", "query": "Mrs. Sample received multiple radiologic examinations. In which order did she receive them?", "options_scores": {"A": 3.291771411895752, "B": 2.0865743160247803, "C": 3.3241472244262695, "D": 3.600639820098877, "E": 3.237694501876831}, "ranked_options": [{"letter": "B", "text": "MR Brain > MR thoracic/lumbar spine > CT chest/abdomen/pelvis > CT Thoracic Spine > CT Thoracic Spine > CT chest/abdomen/pelvis > Abdominal ultrasound > MR Spine > Whole-body PET/CT > Liver MRI", "avg_nll": 2.0865743160247803}, {"letter": "E", "text": "CT Thoracic Spine > CT Whole Body > MR cervical spine > MR Head", "avg_nll": 3.237694501876831}, {"letter": "A", "text": "MR spine > MR Head > CT Thoracic Spine > CT Whole Body", "avg_nll": 3.291771411895752}, {"letter": "C", "text": "MR cervical spine > MR Head > CT Whole Body > CT Thoracic Spine", "avg_nll": 3.3241472244262695}, {"letter": "D", "text": "MR Brain > CT Thoracic Spine > MR cervical spine > CT Whole Body", "avg_nll": 3.600639820098877}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q8", "query": "Mrs. Sample’ medications changed between admission and discharge. Which of the following statements is correct?", "options_scores": {"A": 1.755467176437378, "B": 2.6392464637756348, "C": 1.0784921646118164, "D": 2.7167530059814453, "E": 3.053769111633301}, "ranked_options": [{"letter": "C", "text": "The dose of Sertraline hydrochloride was increased from 50 mg to 100 mg.", "avg_nll": 1.0784921646118164}, {"letter": "A", "text": "Aspirin was discontinued.", "avg_nll": 1.755467176437378}, {"letter": "B", "text": "The patient started taking Pregabalin 50 mg, 1-0-0-0", "avg_nll": 2.6392464637756348}, {"letter": "D", "text": "The patient started taking prednisolone and is recommended to continue taking it for the rest of her life.", "avg_nll": 2.7167530059814453}, {"letter": "E", "text": "The patient started taking 2mg of Melatonin in the evening.", "avg_nll": 3.053769111633301}], "correct_answer_letter": "E", "error": null, "method": "local"}
{"id": "patient_01_q9", "query": "Based on the medication changes from admission to discharge, which of the following best describes the Mrs Sample's evolving clinical situation?", "options_scores": {"A": 2.7389936447143555, "B": 1.6019717454910278, "C": 2.507843255996704, "D": 1.7581182718276978, "E": 2.5304346084594727}, "ranked_options": [{"letter": "B", "text": "The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake.", "avg_nll": 1.6019717454910278}, {"letter": "D", "text": "The patient's mood disorder was deemed stabilized, leading to the discontinuation of Sertraline at discharge.", "avg_nll": 1.7581182718276978}, {"letter": "C", "text": "The patient developed a new gastrointestinal issue, hence the introduction of Pantoprazole at discharge.", "avg_nll": 2.507843255996704}, {"letter": "E", "text": "The patient's immobility concerns were resolved, leading to the discontinuation of Enoxaparin sodium (Clexane®) at discharge.", "avg_nll": 2.5304346084594727}, {"letter": "A", "text": "The patient's cardiovascular risk was decreased, leading to a reduced number of cardiovascular medications at discharge.", "avg_nll": 2.7389936447143555}], "correct_answer_letter": "B", "error": null, "method": "local"}
